October 12, 2017 02:26 PM
A report by the House of Representatives' Office of Congressional Ethics says that there is "substantial reason" to beleive that Representative Chris Collins violated federal law with his actions related to an Australian biotech firm.
The report, which can be found here, was released on Thursday. It states that the House Ethics Committee will continue its investigation of Collins, although it does recommend that one charge related to a possible stock discount be dropped, as it could not be substantiated.
Representative Collins, one of President Trump's biggest allies in Congress, is a board member of Innate Immunotherapeutics Limited and holds stock in the company. is accused of sharing nonpublic information on the purchase of Innate stock, and that he may have used his official actions to assist Innate during a meeting with the National Institutes of Health in 2013. Either of these actions may have violated House rules, standards of conduct, and federal law.
Collins, a Republican, represents New York's 27th district, which covers Orleans, Genesee, Wyoming, Livingston and parts of Erie, Monroe, Niagara and Ontario counties.
Created: October 12, 2017 02:26 PM
Copyright 2017 - WHEC-TV, LLC A Hubbard Broadcasting Company